Loading company…
TL Genomics Inc. develops chromosome-based diagnostic tests, including its SinChro biological age assessment, from Fujisawa, Japan.
Founded in 2015 and based in Kanagawa, Japan, TL Genomics Inc. creates and distributes tests and diagnostic agents for bone marrow transplantation, disease risk assessment through chromosome analysis and fertility testing. Its SinChro biological age assessment uses PCR-based chromosome testing and is offered to individuals and healthcare institutions. In March 2026 the company raised an undisclosed amount of venture funding from Meinan Management Capital and Shizuoka Prefecture as part of a larger venture and grant round. It is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in